L. Yu

发表

Quinoids formed from estrogens and antiestrogens.

J. Bolton, L. Yu, G. Thatcher, 2004, Methods in enzymology.

Oxidation of raloxifene to quinoids: potential toxic pathways via a diquinone methide and o-quinones.

J. Bolton, L. Yu, G. Thatcher, 2004, Chemical research in toxicology.

Identification of novel electrophilic metabolites of piper methysticum Forst (Kava).

J. Bolton, L. Yu, R. V. van Breemen, 2003, Chemical research in toxicology.

Equine estrogen metabolite 4-hydroxyequilenin induces anchorage-independent growth of human mammary epithelial MCF-10A cells: differential gene expression.

J. Bolton, L. Yu, Xuemei Liu, 2004, Mutation research.

Characterization of HKI-272 Covalent Binding to Human Serum Albumin

R. Talaat, A. Mutlib, L. Yu, 2010, Drug Metabolism and Disposition.

Equine catechol estrogen 4-hydroxyequilenin is a more potent inhibitor of the variant form of catechol-O-methyltransferase.

J. Yager, A. Mesecar, J. Bolton, 2004, Chemical research in toxicology.

Efficient Use of the Iron Ortho‐Nitrophenylporphyrin Chloride to Mimic Biological Oxidations of Dimethylaminoantipyrine

G. S. Walker, L. Yu, K. Farley, 2007, Chemical biology & drug design.

Nuclear magnetic resonance spectroscopy as a quantitative tool to determine the concentrations of biologically produced metabolites: implications in metabolites in safety testing.

Jianyao Wang, R. Talaat, A. Mutlib, 2009, Chemical research in toxicology.

Obtaining exposures of metabolites in preclinical species through plasma pooling and quantitative NMR: addressing metabolites in safety testing (MIST) guidance without using radiolabeled compounds and chemically synthesized metabolite standards.

Adedayo Adedoyin, R. Talaat, A. Mutlib, 2009, Chemical research in toxicology.

Bioactivation of lamotrigine in vivo in rat and in vitro in human liver microsomes, hepatocytes, and epidermal keratinocytes: characterization of thioether conjugates by liquid chromatography/mass spectrometry and high field nuclear magnetic resonance spectroscopy.

Hao Chen, A. Mutlib, L. Yu, 2010, Chemical research in toxicology.

A rational chemical intervention strategy to circumvent bioactivation liabilities associated with a nonpeptidyl thrombopoietin receptor agonist containing a 2-amino-4-arylthiazole motif.

G. S. Walker, A. Kalgutkar, A. Mutlib, 2007, Chemical research in toxicology.

Nitrosation, nitration, and autoxidation of the selective estrogen receptor modulator raloxifene by nitric oxide, peroxynitrite, and reactive nitrogen/oxygen species.

J. Bolton, L. Yu, G. Thatcher, 2003, Chemical research in toxicology.

Breast Cancer Resistance Protein (BCRP/ABCG2) is a Major Determinant of Sulfasalazine Absorption and Elimination in the Mouse

J. Ware, L. Yu, Anis A. Khan, 2006, Molecular pharmaceutics.

Breast cancer resistance protein (Bcrp/abcg2) is a major determinant of sulfasalazine absorption and elimination in the mouse.

J. Ware, L. Yu, Anis A. Khan, 2006 .